KneeLife
Home›Treatments›Peripheral nerve stimulation

Peripheral nerve stimulation

Peripheral nerve stimulation

It can test a nerve-modulation strategy without ablating the nerve; temporary and implanted systems offer meaningfully different burdens.

Clinically structured comparison contentReviewed 2026-08-14
PNS changes nerve signaling through temporary or implanted stimulation. It does not correct alignment, instability, or damaged joint surfaces. It does not correct infection, implant loosening, fracture, instability, stiffness, alignment, or damaged joint surfaces.

What this treatment is trying to change

Modulates pain signaling. PNS changes nerve signaling through temporary or implanted stimulation. It does not correct alignment, instability, or damaged joint surfaces.

Compartment / mechanics: Not a compartment-correcting treatment. Pain location alone does not establish the anatomy or candidacy.

When it enters the conversation

  • Persistent focal or neuropathic knee-region pain after a diagnosis-focused evaluation
  • Persistent pain after knee replacement when no clear correctable surgical target has been found

What still has to be confirmed

  • The pain pattern and nerve target
  • Whether a temporary or implanted system is being discussed
  • Correctable structural causes have been assessed

This page explains a treatment role. It does not diagnose the pain source or determine candidacy online.

What treatment involves

One or more leads are placed near a peripheral nerve and connected to an external temporary stimulator or, for selected systems, an implanted pulse generator.

Practical burden: Temporary systems require lead placement, external-device care, dressing management, and later lead removal; implanted systems add a permanent device and implantation/revision considerations.

When benefit may become clear: Benefit may be explored during the treatment period; the meaningful assessment window depends on system type and protocol.

Durability and repeatability: Temporary PNS may have carryover after lead removal in some patients; implanted systems can provide ongoing therapy but require device management. Individual durability is uncertain. A temporary course or implanted-system revision is not an automatic repeat; reassessment is required.

Effect on later options: PNS often preserves orthopedic options, but implanted hardware, lead location, infection history, and imaging compatibility can matter later.

Important tradeoffs

Risks

  • Lead-site infection, bleeding, skin irritation, or pain
  • Lead movement, fracture, or loss of stimulation
  • Uncomfortable stimulation or no benefit
  • Implanted-device revision, removal, battery, and imaging considerations

What patients often notice about the experience

  • Managing an external device and dressings
  • Activity limits that protect a lead
  • Learning stimulation settings
  • Insurance authorization and device-specific costs

Technique variables worth asking about

  • Temporary versus implanted system
  • Nerve target and lead position
  • Ultrasound or fluoroscopic guidance
  • Programming and follow-up protocol

Insurance / cash-pay reality: Coverage and authorization vary sharply by diagnosis, temporary versus implanted system, device, and payer. Confirm the complete episode and follow-up costs.

Four different maturity questions

Evidence, regulatory status, adoption, and access answer different questions. KneeLife does not average them into one grade.

DimensionCurrent levelWhat that means
EvidencedevelopingRandomized evidence supports 60-day PNS for persistent pain after TKA in a small trial; evidence varies by pain condition, nerve target, and device type.
Regulatory / labelingdevelopingTemporary and implanted systems have device-specific indications, clearances, and instructions; do not treat PNS as one interchangeable product.
Clinical adoptiondevelopingUse is growing in pain medicine and PM&R, but knee-specific pathways and target selection vary.
Provider accessdevelopingKneeLife retains 23 source-backed PNS records with device and postsurgical distinctions where documented.

What recovery may look like

Start with burden, time to benefit, and the reassessment point. Open the full timeline only when you need the detail.

Peripheral nerve stimulation

Time to benefit

During the treatment period; timing and carryover depend on system, target, condition, and response.

Usual reassessment point

Programs reassess during programming and at the end of a temporary course; longer follow-up determines whether benefit persists.

Open the detailed recovery timeline

Peripheral nerve stimulation

Before treatment

Complete the cause-focused evaluation, identify a plausible nerve target, review device type, skin/infection risk, medications, work demands, coverage, and follow-up availability.

Treatment or procedure day

A lead is placed near the selected nerve and tested. Temporary systems connect to an external stimulator; implanted systems require a separate implantation pathway.

First 72 hours

Protect the dressing and lead, learn device use, and expect localized soreness. Follow bathing and activity restrictions exactly.

First two weeks

Programming may be adjusted while the lead site is monitored. Daily routines may need modification to prevent lead traction.

Weeks two through six

Use the agreed pain and function goals to judge response while continuing device care and rehabilitation.

Later recovery

Temporary leads are removed at the planned end of treatment; implanted systems require ongoing programming and hardware follow-up.

The later course depends on response, rehabilitation, and the condition being treated.

Time to benefit

During the treatment period; timing and carryover depend on system, target, condition, and response.

Usual reassessment point

Programs reassess during programming and at the end of a temporary course; longer follow-up determines whether benefit persists.

Return to work and activity

  • Desk work may be possible quickly if the lead and dressing can be protected.
  • Heavy, repetitive, wet, or contact work may conflict with lead restrictions and needs a specific plan.

Common temporary symptoms or burdens

  • Lead-site soreness or itching
  • Skin irritation from adhesive
  • Tingling or uncomfortable stimulation
  • Temporary activity inconvenience from the external device

Contact the treating team when

  • Fever, drainage, rapidly increasing redness or swelling, chest pain, shortness of breath, new severe calf symptoms, or a sudden major loss of function.
  • Pain or neurologic symptoms that are severe, rapidly worsening, or materially different from the expected plan.
  • Drainage, spreading redness, fever, lead displacement, device malfunction, new weakness, or an exposed/damaged lead.

What can change the trajectory

  • Device type
  • Nerve target
  • Lead stability
  • Programming
  • Pain mechanism
  • Skin, infection, and work context

Timeline note: These are discussion ranges, not promises. The treating team may use a different plan based on diagnosis, technique, health, work, and response.

What if it works, partly works, or does not work?

Peripheral nerve stimulation

When response is assessed

Judge response during the programmed treatment window and again after temporary-lead removal when carryover is part of the proposed benefit.

What a partial response may mean

Partial improvement may justify programming or goal adjustment, but it does not automatically justify permanent implantation.

Can it be repeated?

Reprogramming, another temporary course, implantation, revision, or removal each requires a separate decision.

Effect on later options

Temporary PNS usually preserves later options; implanted hardware can affect imaging and future procedural planning.

What failure can—and cannot—tell you

Stimulation response may support a nerve-mediated component but is not a definitive diagnosis and does not erase other contributors.

Common next evaluation or treatment branch

Recheck target selection, device programming, rehabilitation, medication and whole-person factors, and whether orthopedic or other-specialty reassessment is needed.

Renew diagnostic or orthopedic evaluation when

  • The cause-focused workup was incomplete or symptoms changed since it was completed.
  • New wound, systemic, neurologic, vascular, instability, swelling, injury, or major functional symptoms appear.

Questions to bring to the visit

  • Why is this nerve the proposed target?
  • Is the system temporary or implanted?
  • What workup makes a pain target reasonable?
  • How will I manage the lead and device?
  • What happens if stimulation helps only partly or stops helping?

Next links

Compare with other treatmentsFind source-backed programsUse the Knee NavigatorReturn to the Treatment Explorer

Sources